External-beam radiation therapy and high-dose rate brachytherapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: Preliminary data on clinical outcome

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages

  Martínez Monge, Rafael ^a   Moreno, Marta ^a   Ciérvide, Raquel ^a   Cambeiro, Mauricio ^a   Pérez Gracia, José Luis ^a   Gil Bazo, Ignacio ^a   Gaztañaga, Miren ^a   Arbea, Leire ^a   Pascual, Ignacio ^a   Aristu, Javier ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

3DCRT; Androgen deprivation therapy; HDR brachytherapy; High risk; Prostate cancer

Indexed keywords

3DCRT; ANDROGEN DEPRIVATION THERAPY; BIOCHEMICAL RELAPSE-FREE SURVIVAL; CLINICAL OUTCOME; DOSE ESCALATION; EXTERNAL-BEAM RADIATION THERAPY; GASTROINTESTINAL TOXICITIES; GLEASON SCORES; HDR BRACHYTHERAPY; HIGH-DOSE-RATE BRACHYTHERAPY; LONG-TERM ANDROGEN DEPRIVATION; PHASE II; PRE-TREATMENT; PRELIMINARY DATA; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY; TIME POINTS; TRANSURETHRAL RESECTION OF THE PROSTATES; URINARY COMPLICATIONS;

DISEASES; ONCOLOGY; THREE DIMENSIONAL; TOXICITY;

RADIOTHERAPY;

ANTIANDROGEN; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BIOCHEMICAL RELAPSE FREE SURVIVAL; BLADDER; BRACHYTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIARRHEA; DOSIMETRY; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL TOXICITY; GLEASON SCORE; HEMATURIA; HIGH RISK PATIENT; HUMAN; INCONTINENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PERINEUM PAIN; PRIORITY JOURNAL; PROCTALGIA; PROCTITIS; PROSPECTIVE STUDY; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RECTUM HEMORRHAGE; RECTUM PAIN; RECURRENCE FREE SURVIVAL; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; TRANSURETHRAL RESECTION; TREATMENT DURATION; TREATMENT OUTCOME; URINARY FREQUENCY; URINARY TOXICITY; URINARY TRACT OBSTRUCTION; URINARY URGENCY;

ANDROGEN ANTAGONISTS; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; ORGANS AT RISK; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RECTUM; ROC CURVE; TREATMENT OUTCOME; URETHRA; URINARY BLADDER; URINATION DISORDERS;

EID: 84856402955     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.08.002     Document Type: Article

References (30)

1. M. Bolla, L. Collette, and L. Blank Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A Phase III randomised trial Lancet 360 2002 103 106
2. G.E. Hanks, T.F. Pajak, and A. Porter Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02 J Clin Oncol 21 2003 3972 3978
3. E.M. Horwitz, K. Bae, and G.E. Hanks Ten-year follow-up of radiation therapy oncology group protocol 92-02: A Phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer J Clin Oncol 26 2008 2497 2504
4. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized Phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
5. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M. D. Anderson Phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105
6. D.P. Dearnaley, M.R. Sydes, and J.D. Graham Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial Lancet Oncol 8 2007 475 487
7. J. Valero, M. Cambeiro, and C. Galan Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: Feasibility report Int J Radiat Oncol Biol Phys 76 2010 386 392
8. R. Martinez-Monge, P.S. Fernandes, and N. Gupta Cross-sectional nodal atlas: A tool for the definition of clinical target volumes in three-dimensional radiation therapy planning Radiology 211 1999 815 828
9. D.J. Demanes, R.R. Rodriguez, and L. Schour High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results Int J Radiat Oncol Biol Phys 61 2005 1306 1316
10. G. Kovacs, and R. Galalae Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: Is lymph node sampling necessary? Cancer Radiother 7 2003 100 106
11. A. Martinez, J. Gonzalez, and W. Spencer Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors J Urol 169 2003 974 979
12. L. Astrom, D. Pedersen, and C. Mercke Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer Radiother Oncol 74 2005 157 161
13. S. Deger, D. Boehmer, and J. Roigas High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer Eur Urol 47 2005 441 448
14. R.M. Galalae, G. Kovacs, and J. Schultze Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer Int J Radiat Oncol Biol Phys 52 2002 81 90
15. V. Beckendorf, S. Guerif, and P.E. Le 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial Int J Radiat Oncol Biol Phys 80 2011 1056 1063
16. A.C. Pellizzon, J.V. Salvajoli, and M.A. Maia Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer J Urol 171 2004 1105 1108
17. O. Cahlon, M.J. Zelefsky, and A. Shippy Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes Int J Radiat Oncol Biol Phys 71 2008 330 337
18. A. Zapatero, F. Valcarcel, and F.A. Calvo Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study J Clin Oncol 23 2005 6561 6568
19. A.A. Martinez, J. Gonzalez, and H. Ye Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy Int J Radiat Oncol Biol Phys 79 2011 363 370
20. A.C. Pellizzon, J. Salvajoli, and P. Novaes Updated results of high-dose rate brachytherapy and external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition Int Braz J Urol 34 2008 293 301
21. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
22. J.M. Michalski, K. Winter, and J.A. Purdy Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V Int J Radiat Oncol Biol Phys 62 2005 706 713
23. J.R. Sathya, I.R. Davis, and J.A. Julian Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate J Clin Oncol 23 2005 1192 1199
24. W.R. Lee, K. Bae, and C. Lawton Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: Analysis of Radiation Therapy Oncology Group study 0019 Cancer 109 2007 1506 1512
25. M. Roach III, K. Bae, and J. Speight Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610 J Clin Oncol 26 2008 585 591
26. J. Crook, C. Ludgate, and S. Malone Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer Int J Radiat Oncol Biol Phys 73 2009 327 333
27. P. Pommier, S. Chabaud, and J.L. Lagrange Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01 J Clin Oncol 25 2007 5366 5373
28. R.G. Stock, J.A. Cesaretti, and S.J. Hall Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy BJU Int 104 2009 1631 1636
29. R.M. Galalae, A. Martinez, and T. Mate Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1048 1055
30. T.P. Phan, A.M. Syed, and A. Puthawala High dose rate brachytherapy as a boost for the treatment of localized prostate cancer J Urol 177 2007 123 127